Prevention of induced nausea and vomiting in patients with malignant blood disorders. Experience of using netupitant/palonosetron (Akynzeo)
نویسندگان
چکیده
Supporting therapy is a necessary component of successful antitumor treatment in patients with both solid tumors and malignant blood disorders. Adherence to administration protocol for antiemetic drugs aimed at prevention induced gastrointestinal complications (nausea vomiting), allows improve patients' quality life compliance. Development combination drug (netupitant/palonosetron) simultaneously affecting 2 main mechanisms nausea vomiting as well its easy allowed significantly control these We present literature review on the effectiveness netupitant/palonosetron describe our own experience using this chemotherapy-induced vomiting.
منابع مشابه
Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.
The supportive care of patients receiving antineoplastic treatment has dramatically improved over the past few years and development of effective measures to prevent nausea and vomiting after chemotherapy serves as one of the most important examples of this progress. A patient who starts cancer treatment with chemotherapy lists chemotherapy-induced nausea and vomiting as among their greatest fe...
متن کاملChemotherapy-induced nausea and vomiting: exploring patients’ subjective experience
BACKGROUND This study aimed to explore the subjective experience of nausea and vomiting during chemotherapy treatment among breast cancer patients and the impacts on their daily lives. METHODS A qualitative descriptive study was conducted in breast cancer patients who received chemotherapy and had experienced nausea and/or vomiting. Semi-structured interviews were conducted and analyzed using...
متن کاملA Comparison of Preoperative Ondansetron and Dexamethasone in the Prevention of Post-Tympanoplasty Nausea and Vomiting
Background: Nausea and vomiting are common complications of anesthesia and surgery. Patients undergoing tympanoplasty are exposed to a higher risk of postoperative nausea vomiting (PONV). These complications may alter the results of reconstruction and anatomical alignments. Numerous antiemetics have been studied to prevent and treat PONV in patients undergoing tympanoplasty. The aim of this stu...
متن کاملPrevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant
Chemotherapy-induced nausea and vomiting (CINV) remains a challenge in cancer care. Improved understanding of CINV pathophysiology has triggered the development of new antiemetic therapeutic options, such as selective neurokinin-1 (NK1) receptor antagonists (RAs), which effectively prevent CINV when added to a standard antiemetic regimen (serotonin-3 RA and dexamethasone). Aprepitant and its wa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: MD-onco
سال: 2022
ISSN: ['2782-3202']
DOI: https://doi.org/10.17650/2782-3202-2022-2-4-71-77